Camilla Qvortrup

Camilla Qvortrup

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
  1. 2021
  2. Published

    Colorectal cancer screening in Europe: what are the next steps?

    Gögenur, Ismail & Qvortrup, Camilla, 2021, In: The Lancet Oncology. 22, 7, p. 898-899 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. 2022
  4. Published

    KRASG12C inhibition in colorectal cancer

    Pfeiffer, P. & Qvortrup, Camilla, 2022, In: The Lancet Oncology. 23, 1, p. 10-11 2 p.

    Research output: Contribution to journalComment/debateResearch

  5. Published

    A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

    Eriksen, M., Pfeiffer, P., Rohrberg, K. S., Yde, C. W., Petersen, L. N., Poulsen, L. Ø. & Qvortrup, Camilla, 2022, In: BMC Cancer. 22, 1, 1321.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    ASO Visual Abstract: ctDNA for Recurrence Risk Assessment in Patients Treated with Neoadjuvant Treatment-A Systematic Review and Meta-analysis

    Gögenur, M., Hadi, N. A. H., Qvortrup, Camilla, Andersen, C. L. & Gögenur, Ismail, 2022, In: Annals of Surgical Oncology. 29, S3, p. 8676 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  7. Published

    DPYD genotyping and dihydropyrimidine dehydrogenase (DPD) phenotyping in clinical oncology. A clinically focused minireview

    Paulsen, N. H., Vojdeman, F., Andersen, Stig Ejdrup, Bergmann, T. K., Ewertz, M., Plomgaard, Peter Stendahl, Hansen, M. R., Esbech, P. S., Pfeiffer, P., Qvortrup, Camilla & Damkier, P., 2022, In: Basic and Clinical Pharmacology and Toxicology. 131, 5, p. 325-346 22 p.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations

    Paulsen, N. H., Qvortrup, C., Vojdeman, F. J., Plomgaard, P., Andersen, S. E., Ramlov, A., Bertelsen, B., Rossing, M., Nielsen, C. G., Hoffmann-Lücke, E., Greibe, E., Spangsberg Holm, H., Nielsen, H. H., Lolas, I. B. Y., Madsen, J. S., Bergmann, M. L., Mørk, M., Fruekilde, P. B. N., Bøttger, P., Petersen, P. C. & 5 others, Nissen, P. H., Feddersen, S., Bergmann, T. K., Pfeiffer, P. & Damkier, P., 2022, In: Acta Oncologica. 61, 11, p. 1400-1405

    Research output: Contribution to journalLetterResearchpeer-review

  9. Published

    Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact

    Jacobsen, I. C., Spanggaard, I., Højgaard, M., Belcaid, L., Qvortrup, Camilla, Yde, C. W., Schmidt, A. Y., Nielsen, Finn Cilius, Willemoe, G. L., Dam, M. S., Lassen, Ulrik Niels & Staal Rohrberg, K., 2022, In: Acta Oncologica. 61, 12, p. 1499-1506 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy

    Eriksen, M., Yde, C. W., Ahlborn, L. B., Qvortrup, Camilla, Lassen, Ulrik Niels, Højgaard, M., Spanggaard, I. & Rohrberg, K. S., 2022, In: European Journal of Cancer. 174, S1, p. S118

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. Published

    ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis

    Gögenur, M., Hadi, N. A. H., Qvortrup, Camilla, Andersen, C. L. & Gögenur, Ismail, 2022, In: Annals of Surgical Oncology. 29, 13, p. 8666-8674

    Research output: Contribution to journalReviewResearchpeer-review

  12. 2023
  13. Published

    Differences in adjuvant chemotherapy and oncological outcomes according to margin status in patients with stage III colon cancer

    Smith, H. G., Skovgaards, D. M., Bui, N. H., Chiranth, D., Qvortrup, Camilla & Schlesinger, N. H., 2023, In: Acta Oncologica. 62, 6, p. 594-600 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 283356767